PRUDENTIAL APPLICANT DRUG TESTING POLICY

If the split testing laboratory believes that the analyte (i.e., drug, drug metabolite, adulterant) is present in the split specimen (Bottle B), but cannot reconfirm its presence, the laboratory must consult with the MRO to decide whether to send the specimen to a third HHS-certified laboratory for additional confirmatory testing. ................
................